总时间（秒）：10.03
问答时间（秒）：7.67

Based on the provided literature, I will extract and standardize the required information according to the predefined JSON framework.

**Variants Include**

* Gene: PARK2
* Variants:
	+ HGVS: NM_004563.3:c.289C>G (standardized via API)
	+ cDNA Change:
		- Transcript: NM_004563.3
		- Ref: C
		- Alt: G
		- Position: 289
	+ Protein Change:
		- Ref: L
		- Alt: V
		- Position: 96
	+ Description in input context: c.289C>G (p.L96V)

**Described Disease**

* Described Disease: Parkinson's disease
* MONDO: MONDO:0005286

**Experiment Method**

* Assay Method: Mitophagy assay
* Material used:
	+ Material Source: Cell line
	+ Material Name: N.D.
	+ Description: N.D.
* Readout type: Quantitative
* Readout description:
	+ Variant: NM_004563.3:c.289C>G
	+ Conclusion: Abnormal
	+ Molecular Effect: partial loss-of-function
	+ Result Description: Parkin activity was reduced by 50% for the variant NM_004563.3:c.289C>G.
* Biological replicates:
	+ Biological replicates: Yes
	+ Description: Three biological replicates were performed.
* Technical replicates:
	+ Technical replicates: No
	+ Description: N.D.
* Basic positive control:
	+ Basic positive control: Yes
	+ Description: Wild-type Parkin was used as a positive control.
* Basic negative control:
	+ Basic negative control: Yes
	+ Description: Empty vector was used as a negative control.
* Validation controls P/LP:
	+ Validation controls P/LP: No
	+ Counts: N.D.
* Validation controls B/LB:
	+ Validation controls B/LB: No
	+ Counts: N.D.
* Statistical analysis method:
	+ Statistical analysis method: N.D.
* Threshold for normal readout:
	+ Threshold for normal readout: N.D.
	+ Source: N.D.
* Threshold for abnormal readout:
	+ Threshold for abnormal readout: N.D.
	+ Source: N.D.
* Approved assay:
	+ Approved assay: No

Note: Some fields are marked as "N.D." because they were not mentioned in the literature.